shamrock7'svideopoker| Buchang Pharmaceutical: Its holding subsidiary's drug clinical trial application accepted

Securities Times e Company News, Buchang Pharmaceutical (603858)(603858) announced on the evening of April 26 that recently, the company's holding subsidiary Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. was researching new indications for the variety "BC008 -1A Injection". The application for clinical trials was accepted by the State Food and Drug Administration, and the proposed indications are glioblastoma, non-small cell lung cancer, esophageal cancer and other advanced solid tumors.

（shamrock7'svideopoker: Congratulations